Publication | Closed Access

Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial

Early TrialCerebrovascular DiseasePharmacotherapyThrombosisStrokeNeurologyPublic HealthPlatelet AntagonistAtherosclerosisIschemic SyndromeCerebral Blood FlowBlinded-endpoint TrialCardiovascular DiseaseIschemic StrokeStroke-related ConditionEarly TreatmentMedicineAnticoagulantAnesthesiology